AHA Coding Clinic® for ICD-9 - 2004 Issue 3; Ask the Editor
Epistaxis Secondary to Coumadin Therapy
An 89-year-old male with a history of congestive heart failure and atrial fibrillation on Coumadin therapy was admitted for treatment of severe epistaxis. The physician was queried regarding the etiology of the bleeding and he documented, “Epistaxis secondary to Coumadin therapy.†Would a code from category 286, Coagulation defects be appropriate? If not, how should this be coded? ...
Subscribe or sign in to view the full article.
Article Overview
This coding article explains how a documented bleeding event associated with Coumadin therapy should be approached in diagnosis coding. It is relevant to inpatient coders, CDI specialists, and compliance staff who work with adverse effects, hemorrhage-related diagnoses, and external cause coding. The article focuses on the coding question, the categories involved, and the general rationale for choosing the appropriate principal diagnosis and accompanying external cause code.
Why This Topic Matters
Accurate coding of medication-related bleeding affects claim integrity, record specificity, and the ability to distinguish the symptom or condition treated from the adverse effect that contributed to it.
What You Will Learn
- How an anticoagulant-associated bleeding scenario is framed for coding review
- How the article distinguishes diagnosis classification from external cause reporting
- Which broad code categories are discussed in relation to medication-related epistaxis
- How the coding question is resolved at a high level
Who Should Read This
- Inpatient medical coders
- Coding educators
- Clinical documentation improvement specialists
- Compliance auditors
- Revenue cycle professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com